特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
909459

ウイルスベクター製造の世界市場

Viral Vector Manufacturing

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 146 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

ウイルスベクター製造の世界市場
出版日: 2020年07月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 146 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のウイルスベクター製造市場について調査分析し、市場概要、主要企業、市場動向・促進要因、世界市場の見通し、地域別市場の分析、競合情勢について、体系的な情報を提供しています。

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界の競合企業の市場シェア
  • 主要企業
  • 市場動向・促進要因
  • 世界市場の見通し

第3章 市場分析

  • 地域別市場の分析
    • 米国
    • カナダ
    • 日本
    • 中国
    • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • その他の欧州
    • アジア太平洋地域
    • その他の世界の地域

第4章 競合

  • CELL AND GENE THERAPY CATAPULT
  • COBRA BIOLOGICS
  • FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A.
  • LONZA GROUP AG
  • MERCK KGAA
  • OXFORD BIOMEDICA PLC
  • SPARK THERAPEUTICS
  • UNIQURE NV

第5章 関連調査

目次
Product Code: MCP15508

Global Viral Vector Manufacturing Market to Reach $1.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Viral Vector Manufacturing estimated at US$383.7 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at a CAGR of 19.9% over the analysis period 2020-2027. Retroviral Vectors, one of the segments analyzed in the report, is projected to record a 17.5% CAGR and reach US$412.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Adenoviral Vectors segment is readjusted to a revised 18.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $113.7 Million, While China is Forecast to Grow at 19.2% CAGR

The Viral Vector Manufacturing market in the U.S. is estimated at US$113.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$236.5 Million by the year 2027 trailing a CAGR of 19.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.8% and 17.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.

Adeno-associated Viral Vectors Segment to Record 27% CAGR

In the global Adeno-associated Viral Vectors segment, USA, Canada, Japan, China and Europe will drive the 26.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$71.6 Million in the year 2020 will reach a projected size of US$375.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$168.8 Million by the year 2027.We bring years of research experience to this 7th edition of our report. The 146-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Cell and Gene Therapy Catapult
  • Cobra Biologics
  • FujiFilm Diosynth Biotechnologies U.S.A., Inc.
  • Lonza Group AG
  • Merck KgaA
  • Oxford Biomedica plc
  • Spark Therapeutics, Inc.
  • uniQure NV

TABLE OF CONTENTS

  • I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Viral Vector Manufacturing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Viral Vector Manufacturing Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: Viral Vector Manufacturing Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: Retroviral Vectors (Type) World Market by Region/Country in US$ Thousand:
  • 2020 to 2027
  • TABLE 4: Retroviral Vectors (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Adenoviral Vectors (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 6: Adenoviral Vectors (Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 7: Adeno-associated Viral Vectors (Type) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 8: Adeno-associated Viral Vectors (Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 9: Other Viral Vectors (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 10: Other Viral Vectors (Type) Market Share Breakdown by Region/Country:
  • 2020 VS 2027
    • TABLE 11: Pharmaceutical and Biopharmaceutical Companies (End-Use) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 12: Pharmaceutical and Biopharmaceutical Companies (End-Use) Distribution of Global Sales by Region/Country: 2020 VS 2027
    • TABLE 13: Research Institutes (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027
    • TABLE 14: Research Institutes (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Viral Vector Manufacturing Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 15: United States Viral Vector Manufacturing Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
    • TABLE 16: United States Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 17: United States Viral Vector Manufacturing Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 18: Viral Vector Manufacturing Market Share Breakdown in the United States by End-Use: 2020 VS 2027
  • CANADA
    • TABLE 19: Canadian Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
    • TABLE 20: Viral Vector Manufacturing Market in Canada: Percentage Share Breakdown of Sales by Type for 2020 and 2027
    • TABLE 21: Canadian Viral Vector Manufacturing Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 22: Canadian Viral Vector Manufacturing Market Share Analysis by End-Use:
  • 2020 VS 2027
  • JAPAN
    • TABLE 23: Japanese Market for Viral Vector Manufacturing: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
    • TABLE 24: Japanese Viral Vector Manufacturing Market Share Analysis by Type: 2020 VS 2027
    • TABLE 25: Japanese Demand Estimates and Forecasts for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 26: Viral Vector Manufacturing Market Share Shift in Japan by End-Use:
  • 2020 VS 2027
  • CHINA
    • TABLE 27: Chinese Viral Vector Manufacturing Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
    • TABLE 28: Chinese Viral Vector Manufacturing Market by Type: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 29: Chinese Demand for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 30: Chinese Viral Vector Manufacturing Market Share Breakdown by End-Use: 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Viral Vector Manufacturing Market: Competitor Market Share Scenario (in %)
    • or 2019 & 2025
    • Market Analytics
    • TABLE 31: European Viral Vector Manufacturing Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 32: European Viral Vector Manufacturing Market Share Shift by Region/Country: 2020 VS 2027
    • TABLE 33: European Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
    • TABLE 34: European Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 35: European Viral Vector Manufacturing Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
    • TABLE 36: European Viral Vector Manufacturing Market Share Analysis by End-Use: 2020 VS 2027
  • FRANCE
    • TABLE 37: Viral Vector Manufacturing Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 38: French Viral Vector Manufacturing Market Share Analysis by Type: 2020 VS 2027
    • TABLE 39: Viral Vector Manufacturing Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
    • TABLE 40: French Viral Vector Manufacturing Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
  • GERMANY
    • TABLE 41: Viral Vector Manufacturing Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
    • TABLE 42: German Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 43: Viral Vector Manufacturing Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
    • TABLE 44: Viral Vector Manufacturing Market Share Distribution in Germany by End-Use: 2020 VS 2027
  • ITALY
    • TABLE 45: Italian Viral Vector Manufacturing Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
    • TABLE 46: Italian Viral Vector Manufacturing Market by Type: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 47: Italian Demand for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 48: Italian Viral Vector Manufacturing Market Share Breakdown by End-Use:
  • 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 49: United Kingdom Market for Viral Vector Manufacturing: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
    • TABLE 50: United Kingdom Viral Vector Manufacturing Market Share Analysis by Type: 2020 VS 2027
    • TABLE 51: United Kingdom Demand Estimates and Forecasts for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 52: Viral Vector Manufacturing Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
    • TABLE 54: Rest of Europe Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 55: Rest of Europe Viral Vector Manufacturing Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
    • TABLE 56: Rest of Europe Viral Vector Manufacturing Market Share Analysis by End-Use: 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 57: Viral Vector Manufacturing Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 58: Asia-Pacific Viral Vector Manufacturing Market Share Analysis by Type:
  • 2020 VS 2027
    • TABLE 59: Viral Vector Manufacturing Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
    • TABLE 60: Asia-Pacific Viral Vector Manufacturing Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
  • REST OF WORLD
    • TABLE 61: Rest of World Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
    • TABLE 62: Viral Vector Manufacturing Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2020 and 2027
    • TABLE 63: Rest of World Viral Vector Manufacturing Market Quantitative Demand Analysis
    • in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 64: Rest of World Viral Vector Manufacturing Market Share Analysis by End-Use: 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 46
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.